Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
University of Otago
Dunedin, Nueva ZelandaPublicacións en colaboración con investigadores/as de University of Otago (30)
2023
-
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance
Arthritis Care and Research, Vol. 75, Núm. 1, pp. 53-60
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom
Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245
2022
-
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86
-
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978
-
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry
ACR Open Rheumatology, Vol. 4, Núm. 10, pp. 872-882
-
Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))
Pharmacopsychiatry
-
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance provider registry
RMD Open, Vol. 8, Núm. 1
2021
-
Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19
JAMA Network Open
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1137-1146
-
Evolutionary and ecological pressures shaping social wasps collective defenses
Annals of the Entomological Society of America, Vol. 114, Núm. 5, pp. 581-595
-
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
The Lancet Rheumatology, Vol. 3, Núm. 10, pp. e707-e714
-
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
The Lancet Rheumatology, Vol. 3, Núm. 12, pp. e855-e864
-
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study
Journal of Psychosomatic Research, Vol. 148
2020
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 859-866
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
-
Repositioning of the global epicentre of non-optimal cholesterol
Nature, Vol. 582, Núm. 7810, pp. 73-77
-
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
The Lancet Rheumatology
2019
2018
-
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i